Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir.

Authors :: Loustaud-Ratti V
Carrier P
Vong C
Essig M
Source :: Hepatology (Baltimore, Md.) [Hepatology] 2014 Jun; Vol. 59 (6), pp. 2426. Date of Electronic Publication: 2014 Apr 14.
Publication Year :: 2014

Subjects :: Female
Humans
Male
Hepatitis C, Chronic drug therapy
Oligopeptides adverse effects
Proline analogs & derivatives
Renal Insufficiency chemically induced

Full Text Access

Tools